[1]CurrentPatentAssignee:INSILICOMEDICINEIPLIMITED-WO2020/198583,2020,A1Locationinpatent:Paragraph000187
[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2018/5881,2018,A1Locationinpatent:Page/Pagecolumn130
[3]CurrentPatentAssignee:AMGENINC-WO2007/98169,2007,A1Locationinpatent:Page/Pagecolumn53
[4]CurrentPatentAssignee:AMGENINC;ROCHEHOLDINGAG-WO2007/100880,2007,A1Locationinpatent:Page/Pagecolumn72
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/37146,2017,A1Locationinpatent:Page/Pagecolumn364;365
[1]CurrentPatentAssignee:CHENGDUHITGENPHARMACEUTICALDEV-CN113264931,2021,ALocationinpatent:Paragraph0037-0038;0043-0044
Title: New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.
Journal: Nature chemical biology 20151101